Evidence map›Paper›PMID 33168747›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics.

Daniel X Hammer, Anant Agrawal, Ricardo Villanueva, Osamah Saeedi, Zhuolin Liu

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05370287 (Adaptive Optics Retinal Imaging), which is not on this map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05370287 narecruitingnot on this map

Adaptive Optics Retinal Imaging

TypeinterventionalSponsorFood and Drug Administration (FDA)Ran2018 to 2028Enrolled150ConditionsGlaucoma, Primary Open AngleArmsoxygen inhalation, Adaptive optics imaging
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Towards noninvasive white blood cell count.Biomedical optics express · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Frontiers in ophthalmology · 2025
    Review
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniel X HammerDivision of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Radiological Devices, Food and Drug Administration, Silver Spring, MD 20993; daniel.hammer@fda.hhs.gov zhuolin.liu@fda.hhs.gov.ORCID 0000-0003-0532-1914
Anant AgrawalDivision of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Radiological Devices, Food and Drug Administration, Silver Spring, MD 20993.ORCID 0000-0001-8573-0042
Ricardo VillanuevaDepartment of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD 21201.ORCID 0000-0002-4144-8296
Osamah SaeediDepartment of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD 21201.
Zhuolin LiuDivision of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Radiological Devices, Food and Drug Administration, Silver Spring, MD 20993; daniel.hammer@fda.hhs.gov zhuolin.liu@fda.hhs.gov.ORCID 0000-0001-8019-2054
Center for Devices and Radiological Health · USUniversity of Maryland, Baltimore · US

Funding

Role of Capillary Flow and Autoregulation in Primary Open Angle GlaucomaK23EY025014 · NEI · UNIVERSITY OF MARYLAND BALTIMORE · PI SAEEDI, OSAMAH JAWAID · 2015 to 2019
$1.0M
NEI NIH HHS K23 EY025014
6 · The paper itself

Abstract

Microglia are resident central nervous system macrophages and the first responders to neural injury. Until recently, microglia have been studied only in animal models with exogenous or transgenic labeling. While these studies provided a wealth of information on the delicate balance between neuroprotection and neurotoxicity within which these cells operate, extrapolation to human immune function has remained an open question. Here we examine key characteristics of retinal macrophage cells in live human eyes, both healthy and diseased, with the unique capabilities of our adaptive optics-optical coherence tomography approach and owing to their propitious location above the inner limiting membrane (ILM), allowing direct visualization of cells. Our findings indicate that human ILM macrophage cells may be distributed distinctly, age differently, and have different dynamic characteristics than microglia in other animals. For example, we observed a macular pattern that was sparse centrally and peaked peripherally in healthy human eyes. Moreover, human ILM macrophage density decreased with age (∼2% of cells per year). Our results in glaucomatous eyes also indicate that ILM macrophage cells appear to play an early and regionally specific role of nerve fiber layer phagocytosis in areas of active disease. While we investigate ILM macrophage cells distinct from the larger sample of overall retinal microglia, the ability to visualize macrophage cells without fluorescent labeling in the live human eye represents an important advance for both ophthalmology and neuroscience, which may lead to novel disease biomarkers and new avenues of exploration in disease progression.

Indexed as

Molecular ImagingOptical ImagingBiomarkersDisease SusceptibilityGlaucomaHumansMacrophagesMacula LuteaMicrogliaNeuroprotectionRetinaTomography, Optical CoherenceBiomarkersadaptive opticsglaucomamacrophagemicrogliaoptical coherence tomography

Identifiers

PMID33168747
PMCPMC7720180
OpenAlexW3098145321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.